Skip to main content
OpenTrials
Completed

NCT Number: NCT03867916

Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to English: Chinese (Cantonese or Mandarin) and Vietnamese.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Caregiver Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Liver Diseases Liver Neoplasms Lung Diseases Lung Neoplasms Malignant Neoplasm Neoplasms Neoplasms by Site Physician Rectal Diseases Respiratory Tract Diseases Respiratory Tract Neoplasms Stage I Colorectal Cancer AJCC v8 Stage I Liver Cancer Stage I Lung Cancer AJCC v8 Stage IA1 Lung Cancer AJCC v8 Stage IA2 Lung Cancer AJCC v8 Stage IA3 Lung Cancer AJCC v8 Stage IB Lung Cancer AJCC v8 Stage II Colorectal Cancer AJCC v8 Stage II Liver Cancer Stage II Lung Cancer AJCC v8 Stage IIA Colorectal Cancer AJCC v8 Stage IIA Lung Cancer AJCC v8 Stage IIB Colorectal Cancer AJCC v8 Stage IIB Lung Cancer AJCC v8 Stage IIC Colorectal Cancer AJCC v8 Stage III Colorectal Cancer AJCC v8 Stage III Liver Cancer Stage III Lung Cancer AJCC v8 Stage IIIA Colorectal Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Stage IIIB Colorectal Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8 Stage IIIC Colorectal Cancer AJCC v8 Stage IIIC Lung Cancer AJCC v8 Thoracic Neoplasms

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, San Francisco

San Francisco, California, 94158, United States

About this study

PRIMARY OBJECTIVES:

I. Identify Asian American adults newly diagnosed with colorectal, liver, or lung cancer using a population-based cancer registry.

II. Conduct outreach to these patients to let them know about the availability of information on these cancers, the Patient Cancer OUtreach, Navigation, Technology and Support (COUNTS) web portal, and the Patient COUNTS patient navigation program.

III. Provide patient navigation either virtually or in-person.

OUTLINE:

Patients attend focus groups to help develop patient portal and navigation program. Patients use in-person navigation program. In phase II, patients use an online portal to access navigation program and may choose to have online/virtual navigation support or in-person navigation support. Patients also complete data collection and surveys over 15 minutes via web portal at baseline, 3 months, and 6 months and user experience survey at end of program participation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • FOR INTERVIEWS AND FOCUS GROUPS:
  • Cancer patients: Self-identifies as Asian American, lives in San Francisco, speaks English, Mandarin, Cantonese, or Vietnamese, has a history of cancer of any kind
  • Caregivers: any person age 21 and older who has provided care to an Asian American cancer patient
  • Health professionals: physicians and other health professionals age 21 and older who provide care to Asian American patients with cancer
  • FOR PILOT IMPLEMENTATION:
  • Self-identifies as Asian American
  • Ages 21 or older
  • Lives in the 9 counties of the greater bay area cancer registry (GBACR)
  • Speaks English, Mandarin, Cantonese, or Vietnamese
  • Has any stage colorectal, lung, or liver cancer
  • Has not started treatment or has not completed treatment
  • Is willing to stay in the study for six months.
  • FOR FULL IMPLEMENTATION:
  • Self-identifies as Asian American
  • Ages 21 or older
  • Lives in the 9 counties of the GBACR
  • Speaks English, Mandarin, Cantonese, or Vietnamese
  • Has any stage colorectal, lung, or liver cancer,
  • Has not started or has not completed treatment
  • Is willing to stay in the study for six-seven months

Exclusion criteria

*Any medical or psychological conditions precluding informed consent

Treatment and study plan

Patient Navigation Program

Behavioral

Use patient navigation program

Other names: Patient Navigator Program

Quality-of-Life Assessment

Other

Ancillary studies

Other names: Quality of Life Assessment

Survey Administration

Other

Ancillary studies

Primary outcomes

  1. Rate of Participation

    Time frame: Any time between consent and month 6

    At least one contact with patient navigator

Secondary outcomes

  1. Adherence to Guideline Treatment

    Time frame: Month 6

    Positive response(s) to survey item(s) on completion of MD-recommended treatment

  2. Patient Acceptability

    Time frame: Month 7

    Response of "satisfied" or "very satisfied" to survey item on satisfaction with Patient COUNTS navigation program

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • Bristol-Myers Squibb

Registry information

Official study title

The Patient Cancer OUtreach, Navigation, Technology, and Support (Patient COUNTS) Project: Addressing Care for Asian Americans With Cancer

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Mar 8, 2019
Registry last updated
Jan 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.